SecBot SecBot
SECBOTREPLAY Home › Report › SEM

SEM · Select Medical Holdings Corporation (SEM) was acquired by a consortium…

SELECT MEDICAL HOLDINGS CORP · 8-K filed Jul 1, 2026 at 09:27 ET

At the news

BULLISHIMPACT 8/10

8-K filed Jul 1, 2026 at 09:27 ET

Select Medical Holdings Corporation (SEM) was acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) in a take-private transaction that closed on June 30, 2026. Shareholders received $16.50 per share in cash, representing an ~18% premium to the unaffected price. The company simultaneously entered into a $1 billion incremental term loan facility to help finance the acquisition. As a result, SEM common stock is being delisted from the NYSE and will be deregistered, with the company becoming a wholly-owned indirect subsidiary of the acquirer.

  • Merger closed on June 30, 2026, effective July 1, 2026 at 12:01 a.m.
  • Shareholders received $16.50 per share in cash, valuing the company at approximately $3.9 billion.
  • The purchase price represents an ~18% premium over the unaffected share price of $13.98 (Nov 24, 2025) and ~25% over the 90-day VWAP.
  • Aggregate purchase price paid for all outstanding shares was approximately $1.7 billion.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access